My interests are in treating patients with sickle cell anemia, myeloproliferative neoplasm, thrombotic disorders, and hematologic malignancy including lymphoproliferative disorders, plasma cell dyscracias, and leukemias.

I have special interests in clinical and translational research involving sickle cell anemia and thrombotic disorders. I have previously done research work on the use of hydroxyurea in sickle cell anemia. I am currently working, in collaboration with Dr. Juneja (Hematology division) and Dr. Yang Xia of the Department of Biochemistry and Molecular Biology, on the role of adenosine in pathophysiology of sickle cell anemia. Our data shows that excess adenosine can increase polymerization of hemoglobin S.

I will also be evaluating the effect of sickle cell anemia on patients’ academic achievement and job performance. This project will be in collaboration with UTHealth School of Public Health.


Medical Degree
Texas Tech University
Texas Tech University
University of Florida College of Medicine

Areas of Interest

Clinical Interests

Benign and malignant hematology disorders including anemias, Thrombocytopenias, Leukopenias, thrombosis, hypercoagulable disorders, coagulopathy, hemoglobinopathies, myeloproliferative disorders, MDS, chronic leukemias and lymphomas, and plasma cell dyscrasias.